BACKGROUND: Statins have been suggested to reduce expansion of abdominal aortic aneurysms (AAAs) independent of lipid-lowering effects. METHODS: We assessed the association of statin treatment and serum low-density lipoprotein (LDL) concentrations with small AAA expansion. Six hundred fifty-two patients undergoing surveillance of small AAAs were entered into the study from 5 vascular centers. In a subset, fasting lipids (n = 451) and other biomarkers (n = 216) were measured. The AAA diameter was followed by ultrasound surveillance for a median of 5 years. RESULTS: Three hundred forty-nine (54%) of the patients were prescribed statins. Adjusting for other risk factors, statin prescription was not associated with AAA growth (odds ratio [OR] 1.23, 95% CI 0.86-1.76). Above-median AAA growth was positively associated with initial diameter (OR 1.78 per 4.35-mm-larger initial aortic diameter, 95% CI 1.49-2.14) and negatively associated with diabetes (OR 0.37, 95% CI 0.22-0.62). Above-median serum LDL concentration was not associated with AAA growth. Patients receiving statins had lower serum C-reactive protein concentrations but similar matrix metalloproteinase-9 and interleukin-6 concentrations to those not prescribed these medications. CONCLUSIONS: We found no association between statin prescription or LDL concentration with AAA expansion. The results do not support the findings of smaller studies and suggest that statins may have no benefit in reducing AAA progression. Copyright (c) 2010 Mosby, Inc. All rights reserved.
BACKGROUND: Statins have been suggested to reduce expansion of abdominal aortic aneurysms (AAAs) independent of lipid-lowering effects. METHODS: We assessed the association of statin treatment and serum low-density lipoprotein (LDL) concentrations with small AAA expansion. Six hundred fifty-two patients undergoing surveillance of small AAAs were entered into the study from 5 vascular centers. In a subset, fasting lipids (n = 451) and other biomarkers (n = 216) were measured. The AAA diameter was followed by ultrasound surveillance for a median of 5 years. RESULTS: Three hundred forty-nine (54%) of the patients were prescribed statins. Adjusting for other risk factors, statin prescription was not associated with AAA growth (odds ratio [OR] 1.23, 95% CI 0.86-1.76). Above-median AAA growth was positively associated with initial diameter (OR 1.78 per 4.35-mm-larger initial aortic diameter, 95% CI 1.49-2.14) and negatively associated with diabetes (OR 0.37, 95% CI 0.22-0.62). Above-median serum LDL concentration was not associated with AAA growth. Patients receiving statins had lower serum C-reactive protein concentrations but similar matrix metalloproteinase-9 and interleukin-6 concentrations to those not prescribed these medications. CONCLUSIONS: We found no association between statin prescription or LDL concentration with AAA expansion. The results do not support the findings of smaller studies and suggest that statins may have no benefit in reducing AAA progression. Copyright (c) 2010 Mosby, Inc. All rights reserved.
Authors: M Mosorin; J Juvonen; F Biancari; J Satta; H M Surcel; M Leinonen; P Saikku; T Juvonen Journal: J Vasc Surg Date: 2001-10 Impact factor: 4.268
Authors: F A Lederle; G R Johnson; S E Wilson; E P Chute; R J Hye; M S Makaroun; G W Barone; D Bandyk; G L Moneta; R G Makhoul Journal: Arch Intern Med Date: 2000-05-22
Authors: J T Powell; A R Brady; L C Brown; F G R Fowkes; R M Greenhalgh; C V Ruckley; S G Thompson Journal: N Engl J Med Date: 2002-05-09 Impact factor: 91.245
Authors: Frank A Lederle; Samuel E Wilson; Gary R Johnson; Donovan B Reinke; Fred N Littooy; Charles W Acher; David J Ballard; Louis M Messina; Ian L Gordon; Edmund P Chute; William C Krupski; Steven J Busuttil; Gary W Barone; Steven Sparks; Linda M Graham; Joseph H Rapp; Michel S Makaroun; Gregory L Moneta; Robert A Cambria; Raymond G Makhoul; Darwin Eton; Howard J Ansel; Julie A Freischlag; Dennis Bandyk Journal: N Engl J Med Date: 2002-05-09 Impact factor: 91.245
Authors: Steven M Santilli; Fred N Littooy; Robert A Cambria; Joseph H Rapp; Alexander S Tretinyak; Alexandre C d'Audiffret; Michael A Kuskowski; Scott T Roethle; Cynthia M Tomczak; William C Krupski Journal: J Vasc Surg Date: 2002-04 Impact factor: 4.268
Authors: Corey S Moran; Paula Clancy; Erik Biros; Bernardo Blanco-Martin; Pamela McCaskie; Lyle J Palmer; Danny Coomans; Paul E Norman; Jonathan Golledge Journal: Clin Endocrinol (Oxf) Date: 2009-04-25 Impact factor: 3.478
Authors: Kimon Bekelis; Jeremy Smith; Weiping Zhou; Todd A MacKenzie; David W Roberts; Jonathan Skinner; Nancy E Morden Journal: Int J Stroke Date: 2015-06-29 Impact factor: 5.266